GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (NYSE:WST) » Definitions » Ending Cash Position

West Pharmaceutical Services (West Pharmaceutical Services) Ending Cash Position : $602 Mil (As of Mar. 2024)


View and export this data going back to 1980. Start your Free Trial

What is West Pharmaceutical Services Ending Cash Position?

West Pharmaceutical Services's Ending Cash Position for the quarter that ended in Mar. 2024 was $602 Mil.

West Pharmaceutical Services's quarterly Ending Cash Position declined from Sep. 2023 ($899 Mil) to Dec. 2023 ($854 Mil) and declined from Dec. 2023 ($854 Mil) to Mar. 2024 ($602 Mil).

West Pharmaceutical Services's annual Ending Cash Position increased from Dec. 2021 ($763 Mil) to Dec. 2022 ($894 Mil) but then declined from Dec. 2022 ($894 Mil) to Dec. 2023 ($854 Mil).

West Pharmaceutical Services Ending Cash Position Historical Data

The historical data trend for West Pharmaceutical Services's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Ending Cash Position Chart

West Pharmaceutical Services Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 439.10 615.50 762.60 894.30 853.90

West Pharmaceutical Services Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 886.30 796.30 898.60 853.90 601.80

West Pharmaceutical Services Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

West Pharmaceutical Services's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=894.3+-40.4
=854

West Pharmaceutical Services's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=853.9+-252.1
=602

West Pharmaceutical Services Ending Cash Position Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

West Pharmaceutical Services (West Pharmaceutical Services) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (NYSE:WST) » Definitions » Ending Cash Position
Comparable Companies
RMD BAX COO HOLX TFX RGEN ATR STVN XRAY MMSI ISRG XPAR:EL BDX TSE:7741 XSWX:ALC OCSE:COLO B XPAR:DIM TSE:4543 XSWX:STMN TSE:7733
Traded in Other Exchanges
WPS:Germany
Address
530 Herman O. West Drive, Exton, PA, USA, 19341-0645
Website
https://www.westpharma.com
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
Executives
Chad Winters officer: VP, CAO & Controller 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Charles Witherspoon officer: VP & Treasurer 530 HERMAN O WEST DRIVE, EXTON PA 19341
Annette F Favorite officer: Sr. VP Human Resources Officer 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Cindy Reiss-clark officer: Senior Vice President 530 HERMAN O. WEST DRIVE, EXTON PA 19341-1147
Quintin J Lai officer: VP Corp Development & Strategy 530 HERMAN 0. WEST DRIVE, EXTON PA 19341
Silji Abraham officer: Chief Digital & Trans Officer 5000 TOWN CENTER, U, SOUTHFIELD MI 48075
Eric Mark Green officer: Chief Executive Officer 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Bernard Birkett officer: Sr VP, CFO & Treasurer 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Thomas W Hofmann director FIVE RADNOR CORPORATE CENTER, SUITE 500, RADNOR PA 19087
Stephen H Lockhart director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Molly Joseph director 9209 GRAND SUMMIT BLVD, DRIPPING SPRINGS TX 78620
Kimberly Banks Mackay officer: SVP, GC & Corporate Secretary 530 HERMAN O. WEST DRIVE, EXTON PA 19341
George Lloyd Miller officer: Sr. VP, GC & Corp. Sec. 530 HERMAN O. WEST DRIVE, EXTON PA 19341
David A Montecalvo officer: SVP, Glob Ops and Supply Chain 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Robert F Friel director 940 WINTER STREET, WALTHAM MA 02451